Publisher： Bentham Science Publishers
ISSN： 2212-7070
Source： Clinical Immunology, Endocrine & Metabolic Drugs, Vol.3, Iss.2, 2017-08, pp. : 140-147
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Wilschanski Michael Kerem Eitan
Expert Opinion on Investigational Drugs, Vol. 20, Iss. 9, 2011-09 ,pp. :
Access to resources
Recommend
Novel Approaches for Potential Therapy of Cystic Fibrosis
Current Drug Targets, Vol. 16, Iss. 9, 2015-01 ,pp. :
Novel Pharmaceutical Approaches for Treating Patients with Cystic Fibrosis
Current Pharmaceutical Design, Vol. 13, Iss. 31, 2007-01 ,pp. :
RNF5, DAB2 and Friends: Novel Drug Targets for Cystic Fibrosis
Current Pharmaceutical Design, Vol. 23, Iss. 1, 2017-02 ,pp. :